Vesugen 20mg
Synthetic Tripeptide Bioregulator | Laboratory Use Only
Vesugen is a synthetic tripeptide (Lys-Glu-Asp, also written KED) from the Khavinson family of short-peptide bioregulators, developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is supplied as a research tool for studying endothelial cell biology, tissue-specific gene expression, and peptide-DNA interaction hypotheses in cell-based and preclinical models.
$91.00
Availability: 10 in stock
Product Overview
- Compound: Vesugen (KED tripeptide, H-Lys-Glu-Asp-OH)
- Class: Short-chain tripeptide bioregulator
- Molecular formula and weight: C₁₅H₂₆N₄O₈, about 390.4 g/mol
- Common strength: 20 mg per vial (confirm yours)
- Format: Lyophilized powder in a sealed glass vial
- Purity: Typically ≥99% by HPLC, with mass spectrometry identity confirmation
- Documentation: Lot-specific Certificate of Analysis (COA)
Research Areas of Interest
- Vascular endothelial cell culture and gene expression
- Angiogenesis-related pathway markers in cell models
- Age-associated cell biology endpoints in preclinical models
- Peptide-DNA interaction and tissue-specific peptide pharmacology
- Comparative structure-activity studies with related Khavinson peptides (such as Livagen, Pancreagen, and Prostamax, which share the KED motif)
